Standard

C-reactive protein and cognitive impairment in patients with bipolar disorder I and II types in remission. / Ashenbrenner, Y.; Chumakov, E.; Kaystrya, I.V.; Dorofeykov, V.V.; Petrova, N.

в: European Neuropsychopharmacology, Том 29, № S6, 2019, стр. S254-S255.

Результаты исследований: Научные публикации в периодических изданиях › тезисы › Рецензирование

Harvard

Ashenbrenner, Y, Chumakov, E, Kaystrya, IV, Dorofeykov, VV & Petrova, N 2019, 'C-reactive protein and cognitive impairment in patients with bipolar disorder I and II types in remission', European Neuropsychopharmacology, Том. 29, № S6, стр. S254-S255. https://doi.org/10.1016/j.euroneuro.2019.09.374

APA

Ashenbrenner, Y., Chumakov, E., Kaystrya, I. V., Dorofeykov, V. V., & Petrova, N. (2019). C-reactive protein and cognitive impairment in patients with bipolar disorder I and II types in remission. European Neuropsychopharmacology, 29(S6), S254-S255. https://doi.org/10.1016/j.euroneuro.2019.09.374

Vancouver

Ashenbrenner Y, Chumakov E, Kaystrya IV, Dorofeykov VV, Petrova N. C-reactive protein and cognitive impairment in patients with bipolar disorder I and II types in remission. European Neuropsychopharmacology. 2019;29(S6):S254-S255. https://doi.org/10.1016/j.euroneuro.2019.09.374

Author

Ashenbrenner, Y. ; Chumakov, E. ; Kaystrya, I.V. ; Dorofeykov, V.V. ; Petrova, N. / C-reactive protein and cognitive impairment in patients with bipolar disorder I and II types in remission. в: European Neuropsychopharmacology. 2019 ; Том 29, № S6. стр. S254-S255.

BibTeX

@article{76829b79d80243a18454854045fa04d6,
title = "C-reactive protein and cognitive impairment in patients with bipolar disorder I and II types in remission",
author = "Y. Ashenbrenner and E. Chumakov and I.V. Kaystrya and V.V. Dorofeykov and N. Petrova",
year = "2019",
doi = "10.1016/j.euroneuro.2019.09.374",
language = "English",
volume = "29",
pages = "S254--S255",
journal = "European Neuropsychopharmacology",
issn = "0924-977X",
publisher = "Elsevier",
number = "S6",
note = "null ; Conference date: 07-09-2019 Through 10-09-2019",
url = "https://2019.ecnp.eu/",

}

RIS

TY - JOUR

T1 - C-reactive protein and cognitive impairment in patients with bipolar disorder I and II types in remission

AU - Ashenbrenner, Y.

AU - Chumakov, E.

AU - Kaystrya, I.V.

AU - Dorofeykov, V.V.

AU - Petrova, N.

PY - 2019

Y1 - 2019

UR - https://www.sciencedirect.com/science/article/pii/S0924977X19312489

U2 - 10.1016/j.euroneuro.2019.09.374

DO - 10.1016/j.euroneuro.2019.09.374

M3 - Meeting Abstract

VL - 29

SP - S254-S255

JO - European Neuropsychopharmacology

JF - European Neuropsychopharmacology

SN - 0924-977X

IS - S6

Y2 - 7 September 2019 through 10 September 2019

ER -

ID: 49647039